No Data
Oriental Biotech: 2024 Annual Results Report Announcement
2024 Annual Results Express Announcement
Zhejiang Orient Gene Biotech (688298.SH) has a net loss of 0.512 billion yuan for the year 2024.
Zhejiang Orient Gene Biotech (688298.SH) released its performance forecast for 2024, indicating that the total operating revenue for the year will be...
Oriental Biotech: 2024 Annual Results Pre-loss Announcement
2024 Annual Results Advance Loss Announcement
January 17 A-shares investment warning highlights︱ *ST Baoxin: Received a preliminary notice of the proposed termination of the company’s Stocks listing; LONGi Green Energy Technology: Expected loss of 8.2 billion yuan to 8.8 billion yuan for the year 202
Zhejiang Orient Gene Biotech: Expected loss of 0.485 billion yuan to 0.535 billion yuan for the year 2024.
Is Zhejiang Orient Gene BiotechLtd (SHSE:688298) Using Debt Sensibly?